Medmain Inc.

📍 港区, Japan🗓 Founded 2018👥 15 employees💰 Last funded Apr 2025
Software Development🌐 en.medmain.com
Website LinkedIn
Medmain Inc. is a company to develop and provide “PidPort”, a pathological AI analysis solution, with a corporate mission of "to create a world where medical services can be accessed with technology anywhere, anytime." “PidPort” is a product that enables the presentation of highly accurate and rapid analysis results by pathology AI developed by deep learning and the online pathological diagnosis such as remote pathological diagnosis. There is a worldwide shortage of "pathologists" who make diagnoses of patients by looking at their tissues and cells to determine whether there is cancer or not and decide the treatment plan, and this has led to serious delays in pathological diagnosis and large regional disparities. With our product “PidPort”, we aim to solve this problem and create a world in which patients can receive a high-quality pathological diagnosis immediately wherever they are.
2
Total investors
1
Early stage
0
Mid stage
1
Late stage
2018
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
1
Japan
1
Frequently asked questions
Who invested in Medmain Inc.?
Medmain Inc. has 2 investors on record on gritt.io, including 1 early-stage backers and 1 late-stage investors.
When did Medmain Inc. last raise funding?
The most recent investment in Medmain Inc. recorded on gritt.io was in April 2025.
When was Medmain Inc. founded?
Medmain Inc. was founded in 2018.
What industry is Medmain Inc. in?
Medmain Inc. operates in Software Development. Find similar Software Development investors on gritt.io.
Where is Medmain Inc. based?
Medmain Inc. is headquartered in 港区, Japan.